Summary Care Records changes made in Covid-19 to carry on while NHS considers permanent change


Share post:

The NHS digital has advised that the temporary changes that were made to Summary Care Records (SCRs) are to continue going forward.

SCR additional information (AI) users will continue to be able to provide and use SCR AI under the UK general data protection regulation and the common law duty of confidentiality.

In response to the Covid-19 pandemic and the passage of related legislation, temporary changes were made to Summary Care Records so that SCRs, by default, could contain additional patient information except where patients had indicated to the NHS that they did not want their data to be shared.

PSNC and the Community Pharmacy IT Group have campaigned for pharmacy teams’ access to SCR AI to be extended beyond the pandemic by sharing case study information.

PSNC and the Royal Pharmaceutical Society both wrote to the relevant authorities within the NHS to share the significant evidence highlighting how SCR AI access for pharmacy teams improves patient safety.

A permanent policy change is being considered by NHS England and NHS Improvement.


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...